Depression is a common condition that impacts people of all races, ethnicities, and income levels. It affects 121 million people worldwide.
- Depression is among the leading causes of disease burden worldwide
- Women, during their childbearing years, are nearly twice as likely as men to experience depression
- People with a family history of depression may be more likely to develop the disease
- People with chronic or debilitating medical conditions may also be susceptible to the disease
Unfortunately, many people suffer in silence with depression. Some are ashamed or afraid to seek help; others try to downplay the severity of their symptoms. It's important to remember that depression isn't something that's "all in your head." Cymbalta can help treat the many symptoms of depression.
Do not take Cymbalta if you are now taking or have recently taken a kind of medicine called a monoamine oxidase inhibitor (also known as an MAOI), including the antibiotic linezolid, or if you are taking Mellaril® (also called thioridazine). Taking Cymbalta close in time to these medicines can cause serious or even life-threatening side effects. If you have uncontrolled narrow-angle glaucoma (eye pain due to increased eye pressure), do not take Cymbalta.
Cymbalta is indicated for the treatment of major depressive disorder (MDD). The efficacy of Cymbalta was established in four short-term trials and one maintenance trial in adults.